# Claret Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/claret-medical

- Industry: Medical Devices & Equipment
- Headquarters: Santa Rosa, US
- Website: www.claretmedical.com
- Total disclosed funding: $33M
- Latest round: Series C (Oct 23, 2017)
- Investors on record: 4

## About

Claret Medical, Inc. develops advanced medical devices specializing in innovative solutions for vascular interventions, focusing on improving patient outcomes through precision engineering and minimally invasive technology.Founded in 2009 in Santa Rosa, US, Claret Medical, Inc. specializes in the design and manufacture of medical devices. In July 2018, the company was acquired by Boston Scientific Corporation for USD 220.00 mn, with an additional potential USD 50.00 mn based on reimbursement-based milestones. The acquisition was completed in August 2018.Claret Medical, Inc. develops innovative medical devices aimed at enhancing vascular interventions. Their offerings include advanced technologies designed to improve patient outcomes in critical therapeutic areas. The company serves a varied global clientele, including hospitals and healthcare providers, focusing on products that address significant medical challenges while ensuring compliance with regulatory standards across different regions.Claret Medical generates revenue through contracts with healthcare providers, focusing on direct sales of its medical devices. The company’s business model includes partnerships with hospitals and clinics, allowing for tailored pricing structures to meet various clinical needs. Their revenue is significantly bolstered by flagship products that cater to high-demand therapeutic areas, facilitating successful treatment outcomes.Claret Medical, Inc. plans to leverage its recent acquisition by Boston Scientific to expand its product offerings and penetrate new markets. The company aims to develop cutting-edge devices that address vascular health challenges and is targeting expansion into European and Asia-Pacific regions by 2022. The funds from the acquisition will be utilized to support product innovation and market entry strategies, enhancing their operational capabilities and reaching a broader clientele.

## Funding rounds

- Series C, Oct 23, 2017, $15M — Easton Capital Investment Group, Sante Ventures, HealthCor Group, Lightstone Ventures
- Series B, Aug 21, 2014, $18M — Easton Capital Investment Group, Sante Ventures, Lightstone Ventures

## Investors

- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series B, Series C
- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series B, Series C
- Lightstone Ventures (https://capitalatlas.ai/funds/lightstone-ventures) — Series B, Series C
- HealthCor Group (https://capitalatlas.ai/funds/healthcor-group) — Series C